OLVG account plan
Medical treatment and hospitality
At a glance
OLVG is Amsterdam's top-clinical teaching city hospital, with more than 6,000 employees and FY2025 operating income of EUR 882.4m.
OLVG (Stichting OLVG) is a Dutch non-profit foundation running the city hospital of Amsterdam, an STZ-recognised top-clinical teaching hospital and one of the seven Santeon hospitals. It operates main locations Oost and West, both with 24/7 emergency care and an Intensive Care, plus outpatient functions at Spuistraat and Medisch Centrum Jan van Goyen, serving Greater Amsterdam for basic care and a regional to national catchment for top-clinical care. FY2025 total operating income was EUR 882.4m (+EUR 70.1m), mostly from health insurers, and the net result EUR 12.9m. The group has more than 6,000 employees and 5,417 average FTE in 2025.
Business units
Stichting OLVG (the hospital)
4,722 FTE in 2025Runs the Oost and West hospitals and the Spuistraat outpatient site, covering acute, clinical, birth and top-clinical care across 15 STZ-recognised top-clinical areas. It took over the outpatient pharmacy of Sint Lucas Andreas Apotheek B.V. Led by the board of Wietske Vrijland (chair), Cees Buren (finance, stepping down 1 June 2026) and Pien Beltman.
OLVG Laboratoria B.V.
590 FTE in 2025Clinical chemistry, medical microbiology and pathology laboratories serving OLVG and other hospitals, expanded with Comicro and Diagnost-IQ in 2024, which lifted subcontracting income to EUR 64.5m. Since 2025 it contracts directly with health insurers and moved into a new gas-free lab building at location West in mid-June 2025.
Medisch Centrum Jan van Goyen B.V.
105 FTE in 2025An independent treatment centre in Amsterdam with outpatient functions and a new OR complex, working with self-employed medical specialists.
Strategic priorities
- Meerjarenstrategie 2026-2029 and care profile
- The new strategy makes sharper choices in care profile, regional collaboration and the balance between basic and top-clinical care, under stricter volume norms, while keeping acute care and birth care.
- OLVG in 2030 location split
- From 2030, West concentrates complex emergency and clinical care (twelve operating rooms, Intensive Care, birth and children's care) and Oost planned operations with eight operating rooms, to end double staffing and reduce emergency department stops.
- Elke Dag Beter efficiency programme
- Running from end 2024 to 2031; registration corrections saved EUR 1 million in 2025 and EUR 1.4 million of overhead reduction potential was identified for 2026.
- Digital and hybrid care
- Digital@OLVG delivered digital check-in, patient self-scheduling and more than 15 new hybrid care paths; Zorg bij Jou with Santeon helped almost 6,000 OLVG patients in 2025 and is to be accelerated in 2026.
- Workforce and absence
- Sick leave rose to 6.7% in 2025 against a 5.0% ambition; 2026 focus on vacancies, absence and wellbeing.
Investments and deals
- New build at location West
- Financing agreement signed 31 March 2026; construction of an entrance building expected to start end 2026, followed by new build phase 1 and renovations at Oost.
- EUR 400m credit facilities
- From 26 March 2026, investment credit facilities of EUR 400m plus EUR 60m working-capital facilities with ABN AMRO, Rabobank, BNG, the Waarborgfonds voor de Zorgsector and the European Investment Bank, for investments in 2026-2031.
- Laboratory building
- A new eight-floor, gas-free laboratory building of almost 8,000 m2 for about 325 staff was delivered mid-June 2025.
- Medical technology and fixed assets
- A second Da Vinci surgical robot; investments in tangible fixed assets of EUR 59.7m and intangibles of EUR 4.8m in 2025.
Challenges and risks
- Staff shortages
- A large shortage of care staff sometimes forces a stop (no ambulances) at the emergency department of Oost or West, and sick leave reached 6.7%.
- Rising staff costs
- Wages, social charges and pensions reached EUR 521.2m; own-staff costs rose EUR 43.3m mainly from CAO and AMS rises.
- Funding dependence and covenants
- Large investments in real estate, medical technology and ICT depend on insurer contributions; EBITDA of EUR 56.5m sits against a EUR 45.0m covenant, and a breach would block investment facilities.
- Outdated buildings
- Both hospital locations need renewal while care continues on site.
- Regulatory and cyber change
- OLVG is preparing for NIS2, the European Data Act and the AI Act, and faces revenue uncertainties from insurer claim settlements and audits.
What leadership says
“you are not lost, you are here”
Where a supplier can help
- Hospital construction and fit-out
- Tied to the new build at West and renovations at Oost: building, operating room and emergency department equipment suppliers align with investments financed through 2031.
- Remote care and hybrid care paths
- Tied to the digital and hybrid care priority: remote monitoring and patient self-service tools support the acceleration of Zorg bij Jou in 2026.
- Workforce relief
- Tied to the staff shortage and absence challenge: scheduling, workflow automation and wellbeing tools address sick leave of 6.7% and emergency department stops.
- Overhead efficiency
- Tied to the Elke Dag Beter programme: administrative and registration automation fits the overhead reduction potential identified for 2026.
- Security and compliance
- Tied to NIS2, Data Act and AI Act preparation: compliance and security services build on NEN 7510 and ISO 27001 certification.
Tamtam's reading of the priorities and challenges above, not the company's own words.
Selling to companies like OLVG?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companiesKey documents
Read in full by Tamtam; each summary links to the document itself.
- OLVG Jaarverantwoording 2025 (Bestuursverslag en jaarrekening)
- OLVG (Stichting OLVG) is the STZ-recognised top-clinical teaching hospital of Greater Amsterdam ("het stadsziekenhuis"), with main locations Oost and West (both 24/7 emergency care and an Intensive Care), outpatient functions at Spuistraat and Medisch Centrum Jan van Goyen; more than 6,000 employees and 5,417 average FTE across the group in 2025.
- FY2025 total operating income (som der bedrijfsopbrengsten) rose EUR 70.1m to EUR 882.4m; health-insurance (Zorgverzekeringswet) income rose EUR 44.7m to EUR 720.5m, largely from annual price indexation (just over 4%).
- Net result EUR 12.9m (2024: EUR 5.3m), 1.5% of consolidated income (0.6%); EBITDA EUR 56.5m against a bank covenant of EUR 45.0m, solvency 30.4% (norm 22%), debt service coverage 3.5 (norm 1.4).
- Costs are dominated by staff: wages, social charges and pensions EUR 521.2m; own-staff costs up EUR 43.3m mainly from CAO and AMS rises; nearly all medical specialists are salaried. Sick leave rose to 6.7%, well above the 5.0% ambition.
- Group entities: OLVG Laboratoria B.V. (590 FTE, with Comicro and Diagnost-IQ acquired in 2024), MC Jan van Goyen B.V. (105 FTE), Stichting Rijdende Röntgen; Sint Lucas Andreas Apotheek B.V.'s activities moved into the foundation and the B.V. will be dissolved in 2026.
- Big real-estate programme: new eight-floor, gas-free laboratory building (almost 8,000 m2, about 325 staff) delivered mid-June 2025; financing agreement for new build at location West signed 31 March 2026; investment credit facilities raised to EUR 400m (from EUR 85m) with ABN AMRO, Rabobank, BNG, the Waarborgfonds voor de Zorgsector and the European Investment Bank, for investments through 2031.
- Strategy: 2025 was the last year of the 2022-2025 strategy; the board drafted a Meerjarenstrategie 2026-2029 with sharper choices in care profile, regional collaboration and the balance between basic and top-clinical care. Efficiency programme Elke Dag Beter runs until 2031.
- Digital and hybrid care: Zorg bij Jou (with the Santeon hospitals) helped almost 6,000 OLVG patients via a hybrid care path in 2025; Digital@OLVG programme, check-in kiosks at Oost and West, more than 15 new hybrid care paths, second Da Vinci surgical robot.
- Key risks: labour-market shortages and absence, dependence on insurer funding for large investments in real estate, medical technology and ICT, and EBITDA covenant pressure (a breach blocks investment facilities).
- Bestuurders Meander MC en OLVG: 'Verandering is pijnlijk en dat moet je zeggen'
- Joint interview by Morgens consultant Annouck de Boer with Wietske Vrijland (chair of the board, OLVG) and Astrid Posthouwer (Meander Medisch Centrum), published 12 May 2026 as partner content on Zorgvisie, on leadership through complex transitions.
- OLVG works since January with a new strategy in which a sharp choice of care profile is a key pillar: what care OLVG will and will no longer deliver.
- Those choices are tied to stricter volume norms, necessary investment choices and keeping crucial basic functions such as acute care and birth care.
- Real estate is a major task: both hospital locations need renewal, and OLVG recently decided to further develop location West, which will carry acute care for a large part of Amsterdam.
- Digitalisation and AI add further pressure to change, on top of strategy and real estate.
- Vrijland's leadership stance: be present, reachable and honest about what is unknown; "you are not lost, you are here".
- She calls transformation in care painful (fewer one-to-one consultations as care moves to remote care) and asks for respect for the staff who change their work.
- Resistance is part of change; the key tool is being a learning organisation; no five-year plan to tick off, but a direction kept alive.
- Toekomstplannen OLVG: wij zorgen voor u, nu en in de toekomst
- OLVG news release of 7 October 2025 presenting "OLVG in 2030": its plans for accessible care in Amsterdam, with a quote from board chair Wietske Vrijland.
- Context given: Amsterdam's population and care demand are growing, there is a large shortage of care staff, and OLVG's buildings need renewal; staff shortages sometimes force a "stop" (no ambulances) at the emergency department of Oost or West.
- From 2030, location West focuses on complex emergency and clinical care: the largest emergency department in the Netherlands, an Intensive Care, birth and children's care, cardiac emergency care, twelve operating rooms and inpatient care for all OLVG specialties.
- From 2030, location Oost focuses on planned operations and treatments (low-complexity surgery such as orthopaedics, ENT, ophthalmology) with eight operating rooms; whether and what form of emergency care stays at Oost is being studied with Huisartsenspoedposten Amsterdam.
- All locations, including Spuistraat, keep outpatient and diagnostic care for all specialties.
- New build at location West and several renovations at Oost; care per specialty is brought together on one location to avoid double staffing, plan better and reduce emergency department stops.
- West was chosen because it has room to expand, Amsterdam Nieuw-West is the fastest-growing district, and Amsterdam UMC concentrated its acute care at AMC and closed location Boelelaan.
Questions about OLVG
What is OLVG?
OLVG is the city hospital of Amsterdam, a non-profit STZ-recognised top-clinical teaching hospital with main locations Oost and West, outpatient functions at Spuistraat and Medisch Centrum Jan van Goyen, and its own laboratory company.
What is OLVG's revenue?
FY2025 total operating income was EUR 882.4m, of which EUR 720.5m from health insurers, with a net result of EUR 12.9m.
How many employees does OLVG have?
More than 6,000 employees, with 5,417 average FTE across the group in 2025.
Who leads OLVG?
Wietske Vrijland has chaired the board since 1 January 2025, with Cees Buren (finance, stepping down 1 June 2026) and Pien Beltman.
What are OLVG's plans for the future?
By 2030 location West will hold complex emergency and clinical care and Oost planned operations, backed by new build at West, renovations at Oost and a Meerjarenstrategie 2026-2029 with sharper care-profile choices.
Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)